Ahead of this month's CPHI Barcelona - the world's largest pharma event, held at Fira Barcelona (October 24-26th, 2023) - and CPHI & PMEC India to be held at India Expo Centre, Greater Noida, Delhi NCR (November 28-30) key highlights from the CPHI pharma survey are announced. The full findings will be published at CPHI Barcelona as part of the CPHI Annual Report.

The results will provide a forward-looking steer on pharma bushiness confidence in the year ahead and feature the insights from more than 250 global pharma executives. In line with wider market sentiments, pharma confidence has dipped below the record scores of 2022, but has remained extremely resilient despite wider macro uncertainly.

In fact, the CPHI Pharma Index - a collateralised metric of all small molecule categories in the survey - reported its second highest ever total, just 2.5% down on the 2022 all-time high. This highly positive result highlights the medium-term trajectory of the industry and the underlying strength of market fundamentals.

The United States unsurprisingly remained the top overall ranked nation (when evaluated across all criteria), with India continuing to make year-on-year inroads and looks well placed for significant growth in 2024 - particularly as the country moves from a generic focussed industry to one that increasingly supports global innovators.

In fact, India remained top of the ‘growth category’ for the second year running (scoring 7.8 out of 10) moving further clear of the United States. The country also saw improvements in its score for 'biologics qualit' and finished only narrowly behind the USA for 'overall competitiveness'. Consequently, the report predicts India is undergoing an accelerating transformation from a generics hub to an innovation focused pharma economy, driven by the incremental steps of its largest CDMOs. India is also predicted to the see the fastest CAGR in biologicals over in the next 5-years, as it quickly builds a bio CDMO base similar to those we have already seen emerge in China and Korea.

Emphasising the country’s surging industry, next month’s CPHI & PMEC India is anticipated to be the largest ever, with record numbers of international attendees, and Indo-western partnering fuelling demand thanks to the shift toward a 'China plus one' strategy. Most startling of all, the report predicts that looking ahead 5-years, we may then be looking at an 'India plus one' strategy as the predominant approach.

"When you look collectively at the data points in the Annual Survey, you see that after a reset from record scores in 2022 - when many reported record profits - the industry is now well positioned for growth in 2024," commented Tara Dougal, Content Director - Pharma.

The report identified that many of the industry’s growth drivers we saw in 2019 are still present, but are now supplemented by the breakthroughs in microbiome therapeutics, mRNA [of course], while AI now looks increasingly likely to drive new efficiencies for the industry over the next 5-years.

Dougal added, "our analysts predict outsourcing will continue its growth trajectory in 2024 and beyond - which is obviously a tremendously positive message for the industry as we approach CPHI Barcelona. It is also why we have ensured that 'outsourcing strategies' are a central theme of this year's content, and the overall takeaway is of quiet and confident optimism. In fact, this will remain an ongoing theme for CPHI content, helping our audience to meet their objectives around partnering and supplier selection year-round."

CPHI Barcelona will welcome the heart of the pharma to its global meeting later this month, and includes a dedicated track on 'partnering for success'. The six session track on day 1 will see industry experts debate the most successful approaches for partner criteria, selection and long term planning. Register to attend CPHI Barcelona today and connect with thousands of industry leaders and expand your network with opportunities to learn, innovate, and collaborate online and in-person.

To download the full copy of the CPHI Annual Report, please visit this page after October 19th 2023: https://www.cphi-online.com/reports/?utm_source=pressrelease&utm_medium=referrer&utm_campaign=HLN00CPO-CL-AnnualReport&utm_content=IN

About CPHI Annual Report

The 2023 CPHI Annual Report’s survey of over 250 industry executives from over 35 countries provides an annual insight into the growth and development of the pharma industry globally. The survey evaluates likely trends for 2024 and assesses the reputations of major pharma markets across more than 10 separate metrics. The findings of the survey will be released in press releases marked “CPHI Annual Survey”. The second component of the CPHI Annual Report features the analysis of ten global experts, each exploring different aspects of the industry today and looks ahead to predict the major trends of tomorrow. The key insights from this will be shared in press releases marked “CPHI Annual Report".

About CPHI

CPHI is the leading global community for pharmaceutical professionals, hosting a portfolio of digital and in-person connection opportunities across the whole pharma supply chain on a scale like no other

At the heart of Pharma

CPHI Barcelona (24-26 October 2023 at Fira Barcelona, Barcelona), CPHI & PMEC India (28-30 November 2023 at the India Expo Mart, Greater Noida, Delhi NCR - Delhi, India); Pharmapack Europe (24-25 Jan, 2024 at Paris Expo, Porte de Versailles - Hall 7.2, Paris). CPHI Japan (17-19 April, 2024 at the Big Sight Exhibition Centre - Tokyo, Japan); CPHI North America (7-9 May, 2024 at Pennsylvania Convention Center, United States); CPHI China (19-21 June 2024 at SNIEC - Shanghai, China); CPHI South East Asia (12-14 Jul 2023 at QSNCC, Bangkok, Thailand); With support from year-round pharma news, products and services at CPHI Online.

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world's leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.